Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kiromic Biopharma Inc (KRBP)

Kiromic Biopharma Inc (KRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kiromic Biopharma Inc 7707 FANNIN ST. SUITE 200 HOUSTON TX 77054 USA

www.kiromic.com Employees: 44 P: 832-968-4888

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Kiromic BioPharma Inc. is a discovery and gene-editing company utilizing artificial intelligence and a proprietary neural network platform with a therapeutic focus on immuno-oncology. Kiromic BioPharma Inc. is based in HOUSTON.

Key Statistics

Overview:

Market Capitalization, $K 251
Enterprise Value, $K -1,549
Shares Outstanding, K 1,571
Float, K 1,247
% Float 79.41%
Short Volume Ratio 0.25
% of Insider Shareholders 20.59%
% of Institutional Shareholders 10.91%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -26,900 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,490 K
EBIT, $ -15,700 K
EBITDA, $ -13,470 K

Growth:

1-Year Return -94.68%
3-Year Return -99.39%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.11 on 02/14/25
Next Earnings Date 05/09/25
Earnings Per Share ttm -3.50
EPS Growth vs. Prev Qtr -70.77%
EPS Growth vs. Prev Year 73.32%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 03/13/23

KRBP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -277.46%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -8.23
Interest Coverage -6.23
60-Month Beta 1.66
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar